Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 279

Results For "RI"

11123 News Found

Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya
News | April 25, 2022

Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya

April 25th is commemorated as World Malaria Day


Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah
News | April 25, 2022

Thermo Fisher opens bioprocessing manufacturing site in Ogden, Utah

The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19


‘DREAM-ND’ and ‘DREAM-D’ Phase 3 trials of Desidustat published in American Journal of Nephrology
Biotech | April 25, 2022

‘DREAM-ND’ and ‘DREAM-D’ Phase 3 trials of Desidustat published in American Journal of Nephrology

Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia


CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment
Drug Approval | April 23, 2022

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment

If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe


Novavax initiates Covid-19 booster study in adolescents in Phase 3 trial
Biotech | April 23, 2022

Novavax initiates Covid-19 booster study in adolescents in Phase 3 trial

Continuation of pediatric expansion in adolescents of PREVENT-19 Phase 3 trial will evaluate safety and immunogenicity of a booster dose


Brinton Pharmaceuticals to invest GBP 30 million for R&D centre in UK
Biotech | April 23, 2022

Brinton Pharmaceuticals to invest GBP 30 million for R&D centre in UK

The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences


USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial
Biotech | April 22, 2022

USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial

The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic


First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal
Public Health | April 22, 2022

First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal

The first use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter


KBI Biopharma opens mammalian manufacturing facility in North Carolina
News | April 22, 2022

KBI Biopharma opens mammalian manufacturing facility in North Carolina

Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina


Aurobindo Pharma signs MoU with Hare Krishna Charitable Foundation
Sustainability | April 22, 2022

Aurobindo Pharma signs MoU with Hare Krishna Charitable Foundation

A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh